TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22340371

Group type: EXPERIMENTAL
Intervention: Pressure bandage and tape
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Pressure bandage and brace
Number of subjects: 180

Group type: COMPARATOR
Intervention: No external support
Number of subjects: 180
Study: 20375696

Group type: EXPERIMENTAL
Intervention: Combined therapy (pressure therapy + silicone gel sheeting)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Pressure therapy (PG)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Silicone gel sheeting (SGS)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 17379120

Group type: EXPERIMENTAL
Intervention: Postoperative nausea and vomiting (PONV) assessment at various time intervals (0‐2, 2‐6, and 6‐24 hours) using a 4‐point scale
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Tympanometric measurements (gradient, compliance, pressure)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Volume measurements of both ears
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Correlation analysis between middle ear pressure changes and PONV
Number of subjects: 49
Study: 15670021

Group type: EXPERIMENTAL
Intervention: Postdischarge Dalteparin for 1 week
Number of subjects: 209

Group type: COMPARATOR
Intervention: No further prophylaxis
Number of subjects: 209
Study: 12102384

Group type: EXPERIMENTAL
Intervention: Usual care plus nurse-delivered intervention based on cognitive-behavioural principles
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 80
Study: 10336100

Group type: EXPERIMENTAL
Intervention: Induced elated mood with forbidden foods in imagined eating situations
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Induced depressed mood with forbidden foods in imagined eating situations
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Induced elated mood with non-forbidden foods in imagined eating situations
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Induced depressed mood with non-forbidden foods in imagined eating situations
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Eating forbidden foods in real eating situations
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Eating non-forbidden foods in real eating situations
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Imagining eating forbidden foods
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Imagining eating non-forbidden foods
Number of subjects: 212
Study: 8535536

Group type: EXPERIMENTAL
Intervention: Beta-receptor blockers and/or diuretics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium antagonists, alpha 1 blockers, and ACE inhibitors
Number of subjects: 0
Study: 2227079

Group type: EXPERIMENTAL
Intervention: Nimesulide (100 mg rectally, administered one to three times daily for a mean period of 2.5 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dipyrone (controlled group, administered one to three times daily for a mean period of 2.5 days)
Number of subjects: 50
Study: 324577

Group type: EXPERIMENTAL
Intervention: Treatment for mild hypertension
Number of subjects: 1800
Study: 31989472

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 31386646

Group type: EXPERIMENTAL
Intervention: General population screening for vascular disease
Number of subjects: 0
Study: 27811526

Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB)
Number of subjects: 93
Study: 24983295

Group type: EXPERIMENTAL
Intervention: Modified constraint‐induced movement therapy (CIMT)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hand‐arm bimanual intensive therapy (HABIT)
Number of subjects: 12
Study: 24654314

Group type: EXPERIMENTAL
Intervention: MP29-02 (1 spray/nostril bid)
Number of subjects: 612

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) nasal spray (2 sprays/nostril qd)
Number of subjects: 612
Study: 21271793

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg plus Ezetimibe 10 mg
Number of subjects: 100
Study: 19432566

Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg) and Vitamin E (400 iu) daily until delivery
Number of subjects: 1365
Study: 16415406

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Open cholecystectomy
Number of subjects: 28
Study: 15257794

Group type: EXPERIMENTAL
Intervention: 45 mg primaquine
Number of subjects: 89

Group type: COMPARATOR
Intervention: No primaquine (Control)
Number of subjects: 89
Study: 11747872

Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG taken 12 h apart on day 10 of the cycle (Group A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG at the time of serum LH surge (Group B)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG 48 h after positive detection of urinary LH (Group C)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.75 mg LNG during late follicular phase (Group D)
Number of subjects: 45
Study: 9413765

Group type: EXPERIMENTAL
Intervention: Sorbitol-mannitol irrigation fluid (2.7% sorbitol and 0.54% mannitol)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 92
Study: 8400610

Group type: EXPERIMENTAL
Intervention: Calcium gluconolactate (CG)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Calcium gluconolactate (CG')
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate (TCP)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Calcium citrate (CC)
Number of subjects: 10
Study: 3546949

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) plus cis‐diamminodichloroplatinum (DDP)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CTX) plus BCG treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Cyclophosphamide (CTX)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Patients with pretreatment residual disease less than 2 cm
Number of subjects: 6

Group type: COMPARATOR
Intervention: Univariate analysis of pretreatment prognostic factors
Number of subjects: 6
Study: 29771563

Group type: EXPERIMENTAL
Intervention: Sadness induction
Number of subjects: 60

Group type: COMPARATOR
Intervention: No emotional induction (control)
Number of subjects: 60
Study: 25766509

Group type: EXPERIMENTAL
Intervention: Plyometric training (6 weeks, 3 sessions/week)
Number of subjects: 27
Study: 23711798

Group type: EXPERIMENTAL
Intervention: Imageless navigation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 40
Study: 23616154

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20012877

Group type: EXPERIMENTAL
Intervention: Incredible Years parent training program (PT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined parent training and child treatment (PT + CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 18753925

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 2752

Group type: COMPARATOR
Intervention: Didanosine
Number of subjects: 2752

Group type: COMPARATOR
Intervention: Other NRTIs
Number of subjects: 2752
Study: 15961987

Group type: EXPERIMENTAL
Intervention: Xenadrine RFA (25 mg ephedra alkaloids and 200 mg caffeine)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ephedra-guarana
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Xenadrine RFA
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 16
Study: 12869911

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide aqueous nasal spray (TAA AQ) 220 microg daily
Number of subjects: 295

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 200 microg daily
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Both TAA AQ and FP
Number of subjects: 295
Study: 10553743

Group type: EXPERIMENTAL
Intervention: Prolonged exposure (N = 14)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prolonged exposure plus anxiety management (N = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Supportive counseling (N = 16)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prolonged exposure (N = 13)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prolonged exposure plus anxiety management (N = 13)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Supportive counseling (N = 15)
Number of subjects: 45
Study: 8551406

Group type: EXPERIMENTAL
Intervention: 5 mg/kg per day oral prednisone for 6 to 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3 mg/kg per day oral prednisone for 6 to 12 weeks
Number of subjects: 60
Study: 1702493

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (cisplatin-based combination chemotherapy)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no adjuvant chemotherapy)
Number of subjects: 86
Study: 6682631

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Military dependent population
Number of subjects: 246
Study: 30887627

Group type: EXPERIMENTAL
Intervention: Incremental Shuttle Walk Test (ISWT)
Number of subjects: 50
Study: 27839810

Group type: EXPERIMENTAL
Intervention: 1-mm sampling interval
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 0.6-mm sampling interval
Number of subjects: 38
Study: 26644115

Group type: EXPERIMENTAL
Intervention: Memory training (composite of Hopkins Verbal Learning Test, Rey Auditory Verbal Learning Test, Rivermead Behavioral Memory Test)
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Reasoning training (composite of letter series, letter sets, word series)
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: Speed of processing training (measured using useful field of view and digit symbol substitution test)
Number of subjects: 2800

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 2800
Study: 23830530

Group type: EXPERIMENTAL
Intervention: Subcutaneous fentanyl
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 22217192

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/Losartan 50 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/Losartan 50 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/Losartan 100 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/Losartan 100 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/Losartan 5 mg/50 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/Losartan 5 mg/100 mg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Amlodipine camsylate/Losartan 10 mg/50 mg
Number of subjects: 320

Group type: COMPARATOR
Intervention: Amlodipine camsylate/Losartan 10 mg/100 mg
Number of subjects: 320
Study: 19533522

Group type: EXPERIMENTAL
Intervention: High-frequency (HF) TENS (80 Hz)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-frequency (LF) TENS (burst of 2 Hz)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 24
Study: 18166819

Group type: EXPERIMENTAL
Intervention: Medical therapy
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 131

Group type: COMPARATOR
Intervention: Radioiodine therapy
Number of subjects: 131
Study: 16259286

Group type: EXPERIMENTAL
Intervention: 1000 mg of dietary calcium plus physical activity 30 minutes three times per week
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 600 mg of calcium citrate plus 500 mg of dietary calcium and physical activity three times per week
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study: 12181213

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary exercise testing
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 67
Study: 10190267

Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 7479227

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) treatment using cuprophan dialyzers and acetate containing solution (35 mEq/l), 4 hours, 3 times weekly.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) treatment (group I with hypotensive episodes).
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) treatment (group II without hypotensive episodes).
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (healthy subjects).
Number of subjects: 20
Study: 2205694

Group type: EXPERIMENTAL
Intervention: Continuous positive pressure breathing (19 ± 1 mm Hg for 30 minutes) after water loading
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Continuous negative pressure breathing (11 ± 1 mm Hg for 30 minutes) after maintenance water ingestion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control day without pressure breathing
Number of subjects: 7
Study: 6997154

Group type: EXPERIMENTAL
Intervention: Eprazinone dihydrochloride (Eftapan)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 30905546

Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) applied for 5 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 36
Study: 28056906

Group type: EXPERIMENTAL
Intervention: Behavioural change interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 25719252

Group type: EXPERIMENTAL
Intervention: CEM‐530
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Perseus
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: CellChek XL
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: EM‐3000
Number of subjects: 69

Group type: COMPARATOR
Intervention: All devices
Number of subjects: 69
Study: 24434526

Group type: EXPERIMENTAL
Intervention: Rivastigmine capsules (12 mg/d)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Rivastigmine patch (9.5 mg/24 h)
Number of subjects: 583
Study: 21718259

Group type: EXPERIMENTAL
Intervention: SPA (Seattle Protocol for Activity)
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: SPA+HP
Number of subjects: 273

Group type: COMPARATOR
Intervention: RMC (Routine Medical Care)
Number of subjects: 273

Group type: COMPARATOR
Intervention: HP (Health Promotion)
Number of subjects: 273
Study: 19303012

Group type: EXPERIMENTAL
Intervention: Budesonide (9 mg/d) for 6 weeks
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Open-label budesonide (9 mg/d) for 6 additional weeks after placebo
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 42
Study: 17570997

Group type: EXPERIMENTAL
Intervention: Latanoprost and brinzolamide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 22
Study: 14766438

Group type: EXPERIMENTAL
Intervention: Buspirone treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study: 11148439

Group type: EXPERIMENTAL
Intervention: Nepean Dyspepsia Index quality-of-life scales
Number of subjects: 589

Group type: EXPERIMENTAL
Intervention: 10-item short form (SF; short form-Nepean Dyspepsia Index)
Number of subjects: 589

Group type: COMPARATOR
Intervention: Nepean Dyspepsia Index
Number of subjects: 589
Study: 9779838

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclosporin A plus hydroxychloroquine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study: 7512131

Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 304

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 304
Study: 3418376

Group type: EXPERIMENTAL
Intervention: BCG therapy
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control (no BCG therapy)
Number of subjects: 43
Study: 30816167

Group type: EXPERIMENTAL
Intervention: DNA methylation analysis in urine
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: hrHPV testing on urine
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Methylation levels in urine
Number of subjects: 41
Study: 28318077

Group type: EXPERIMENTAL
Intervention: Recorded maternal voice played for 10 minutes before and after venipuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: No sound therapy intervention (Control)
Number of subjects: 60
Study: 26024727

Group type: EXPERIMENTAL
Intervention: Lenalidomide 10 mg/day for 9 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 23011321

Group type: EXPERIMENTAL
Intervention: 0.3 mg FC + hCRH
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.1 mg FC + hCRH
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.075 mg FC + hCRH
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.05 mg FC + hCRH
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo + hCRH
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.3 mg FC + placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.1 mg FC + placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.075 mg FC + placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.05 mg FC + placebo
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo p.o. + placebo i.v.
Number of subjects: 8
Study: 21530292

Group type: EXPERIMENTAL
Intervention: U‐Clips
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard 8/0 polypropylene running suture
Number of subjects: 30
Study: 18261121

Group type: EXPERIMENTAL
Intervention: AstraTech implants
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Brånemark implants
Number of subjects: 54

Group type: COMPARATOR
Intervention: Implant sites
Number of subjects: 54

Group type: COMPARATOR
Intervention: Tooth sites
Number of subjects: 54

Group type: COMPARATOR
Intervention: Presence of Staphylococcus aureus
Number of subjects: 54
Study: 16987366

Group type: EXPERIMENTAL
Intervention: Optimized pre‐operative information and enforced mobilization and nutrition
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional peri‐operative care
Number of subjects: 79
Study: 14586921

Group type: EXPERIMENTAL
Intervention: Acetic acid iontophoresis plus physiotherapy (n=18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham acetic acid iontophoresis plus physiotherapy (n=18)
Number of subjects: 36
Study: 11029681

Group type: EXPERIMENTAL
Intervention: Antidepressants (tricyclics, selective serotonin reuptake inhibitors, S-adenosylmethionine)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 16
Study: 9415344

Group type: EXPERIMENTAL
Intervention: Simvastatin plus fenofibrate
Number of subjects: 29

Group type: COMPARATOR
Intervention: Simvastatin plus cholestyramine
Number of subjects: 29
Study: 8233289

Group type: EXPERIMENTAL
Intervention: 0.4 g/kg BW IVIG
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.8 g/kg BW IVIG
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IVIG treatment
Number of subjects: 100
Study: 3157346

Group type: EXPERIMENTAL
Intervention: Aztreonam, 1 g intramuscularly
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spectinomycin, 2 g intramuscularly
Number of subjects: 0
Study: 31931894

Group type: EXPERIMENTAL
Intervention: Mirtazapine and placebo (n = 68)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Paroxetine and placebo (n = 68)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Mirtazapine and paroxetine (n = 68)
Number of subjects: 204
Study: 31307050

Group type: EXPERIMENTAL
Intervention: Intervention study with trained listeners analyzing recordings
Number of subjects: 119
Study: 30293689

Group type: EXPERIMENTAL
Intervention: Proanthocyanidin (6.5wt%; PA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Glutaraldehyde (5wt%; GA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: UVA-activated riboflavin (0.5wt%; RB)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 60
Study: 26467779

Group type: EXPERIMENTAL
Intervention: Frequent hemodialysis (6 sessions/week)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Conventional hemodialysis (3 sessions/week)
Number of subjects: 245
Study: 25269896

Group type: EXPERIMENTAL
Intervention: Platelet function monitoring guided antiplatelet therapy (adjusted aspirin to 200 mg/d if AA-induced IPA <50%, adjusted clopidogrel to 150 mg/d if ADP-induced IPA <30%)
Number of subjects: 384

Group type: COMPARATOR
Intervention: Conventional dual antiplatelet therapy (standard treatment)
Number of subjects: 384
Study: 23217188

Group type: EXPERIMENTAL
Intervention: MAKS therapy (motor stimulation, practice of activities of daily living, cognitive stimulation), 2 hours, 6 days a week for 12 months.
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (standard nursing home care)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: MAKS therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: MAKS therapy and Control group
Number of subjects: 61
Study: 20052694

Group type: EXPERIMENTAL
Intervention: Preventive intervention including parenting skills and social skills training between 7 and 9 years of age
Number of subjects: 895

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 895
Study: 18262450

Group type: EXPERIMENTAL
Intervention: Oxycodone-gabapentin
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo-gabapentin
Number of subjects: 338
Study: 15984630

Group type: EXPERIMENTAL
Intervention: Adapalene 0.1% cream and gel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tazarotene cream 0.05% and 0.1%
Number of subjects: 30

Group type: COMPARATOR
Intervention: Negative control product
Number of subjects: 30
Study: 12906339

Group type: EXPERIMENTAL
Intervention: Monolithic osmotic tablet system (MOTS) containing nifedipine, 30 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Commercial Adalat osmotic tablet system containing nifedipine, 30 mg
Number of subjects: 11
Study: 10648749

Group type: EXPERIMENTAL
Intervention: Local anesthesia
Number of subjects: 164

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 164
Study: 9315427

Group type: EXPERIMENTAL
Intervention: Median-based t-like statistic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paired t-test
Number of subjects: 0
Study: 1527273

Group type: EXPERIMENTAL
Intervention: Psychotherapy without active medication
Number of subjects: 52